Pharma firms have asked govt for a forecast on Covid trajectory to meet demand since manufacturing remdesivir takes time, by which time a vaccine could become available.
Glenmark conducted phase 3 clinical trials of favipiravir on 150 mild to moderate Covid patients. Adverse events, or side effects, reported in 32 patients.
In an interview to ThePrint, Panjak R. Patel, chairman of Zydus Cadila, says company has already manufactured clinical batches of the vaccine candidate for phase 1 and 2 trials.
Complaint by MP to DCGI also highlights that the cost proposed by Glenmark is ‘definitely not in the interest of the poor, lower middle class and middle-class people of India’.
Oxford vaccine is under Phase II/III trials in multiple countries, where many have been given the vaccine & are being followed up with — a process that consumes time, but is standard.
RSS is expected to play a crucial role in picking PM Modi’s successor when the time comes but things will change if BJP doesn’t need it to win elections.
India’s defence sector is trying to penetrate the African market. But with China already extending significant influence, India must now play catch-up.
Discussion about outcome of Lok Sabha polls continues to boil in cauldron of expectations only from BJP. Now reverse this equation, what if we asked about the performance of the 'loser'?
COMMENTS